[go: up one dir, main page]

NO20001895L - Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer - Google Patents

Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer

Info

Publication number
NO20001895L
NO20001895L NO20001895A NO20001895A NO20001895L NO 20001895 L NO20001895 L NO 20001895L NO 20001895 A NO20001895 A NO 20001895A NO 20001895 A NO20001895 A NO 20001895A NO 20001895 L NO20001895 L NO 20001895L
Authority
NO
Norway
Prior art keywords
glycosaminoglycans
diabetes
preparation
treatment
pharmaceutical preparations
Prior art date
Application number
NO20001895A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001895D0 (no
Inventor
Fokko Van Der Woude
Dieter Herr
Volker Laux
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20001895L publication Critical patent/NO20001895L/no
Publication of NO20001895D0 publication Critical patent/NO20001895D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20001895A 1997-10-24 2000-04-12 Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer NO20001895D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747195A DE19747195A1 (de) 1997-10-24 1997-10-24 Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
PCT/EP1998/006703 WO1999021538A2 (fr) 1997-10-24 1998-10-22 Utilisation de glycosaminoglycanes pour la fabrication de preparations pharmaceutiques en vue du traitement de maladies des yeux associees au diabete

Publications (2)

Publication Number Publication Date
NO20001895L true NO20001895L (no) 2000-04-12
NO20001895D0 NO20001895D0 (no) 2000-04-12

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001895A NO20001895D0 (no) 1997-10-24 2000-04-12 Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer

Country Status (13)

Country Link
EP (1) EP1047434A2 (fr)
JP (1) JP2001520987A (fr)
KR (1) KR20010024550A (fr)
CN (1) CN1277554A (fr)
AU (1) AU749673B2 (fr)
BR (1) BR9813098A (fr)
CA (1) CA2306379A1 (fr)
DE (1) DE19747195A1 (fr)
HU (1) HUP0004647A3 (fr)
IL (1) IL135171A0 (fr)
NO (1) NO20001895D0 (fr)
WO (1) WO1999021538A2 (fr)
ZA (1) ZA989665B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
JPWO2011122321A1 (ja) * 2010-03-29 2013-07-08 国立大学法人名古屋大学 ヘパリン結合性蛋白に対する生理活性阻害剤
CN107137421A (zh) * 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
ATE81462T1 (de) * 1988-06-27 1992-10-15 Roland Reiner Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
AU7520394A (en) * 1993-08-13 1995-03-14 Glycomed Incorporated Bridged oligosaccharides and sulfated derivatives thereof
EP0722326A4 (fr) * 1993-10-07 1999-10-06 Glycomed Inc Maltooligosaccharides fortement sulfatees presentant des proprietes semblables a l'heparine
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
WO1999004801A1 (fr) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Utilisation de glycosaminoglycanes sulfates dans le traitement de la retinopathie

Also Published As

Publication number Publication date
JP2001520987A (ja) 2001-11-06
AU1335599A (en) 1999-05-17
KR20010024550A (ko) 2001-03-26
CN1277554A (zh) 2000-12-20
WO1999021538A2 (fr) 1999-05-06
DE19747195A1 (de) 1999-04-29
BR9813098A (pt) 2000-08-15
HUP0004647A2 (hu) 2001-05-28
WO1999021538A3 (fr) 1999-08-05
IL135171A0 (en) 2001-05-20
AU749673B2 (en) 2002-07-04
ZA989665B (en) 2000-04-25
HUP0004647A3 (en) 2002-01-28
CA2306379A1 (fr) 1999-05-06
EP1047434A2 (fr) 2000-11-02
NO20001895D0 (no) 2000-04-12

Similar Documents

Publication Publication Date Title
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
FI20000720L (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
NO910874D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
FI964619L (fi) Epilepsialääkkeiden iholle annostelu
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
FI982689L (fi) 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen
DE69618560D1 (de) Medikament gegen ophthalmische erkrankungen
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
NO20001895L (no) Anvendelse av glykosaminoglykaner for fremstilling av farmasøytiske preparater for behandling av diabetes assosierte- øyesykdommer
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
EP0990441A4 (fr) Medicament pour le traitement de la nephropathie diabetique
DE69840432D1 (de) Arzneimittel zur behandlung der augen
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
DE69722178D1 (de) Therapeutischer wirkstoff für augenerkrankungen
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
FI950649L (fi) Substituoidut sykloheksanoliesterit, niiden käyttö sairauksien hoitamiseksi ja farmaseuttiset valmisteet
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
AU3651595A (en) Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application